QIAGEN Launches Liquid Biopsy Workflow for GeneReader NGS System
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Increasing speed and sensitivity with 2D-LC
Learn how a cutting-edge tool is being used by drug development scientists to optimize preclinical studies
Scientists discuss the speed, reproducibility, and versatility of the Countstar Mira cell counting range
Ribbon Bio Co-founder, Wladimir Labeikovsky, provides unique perspectives on synthetic DNA and discusses the company’s commitment to producing pure and accurate synthetic DNA molecules
Learn how organ-on-a-chip technology is aiding toxicologists in de-risking drug-induced liver injury by providing human-specific safety data
Comparison of graphene, graphene oxide and reduced graphene oxide
A Rapid Screening Method to Identify Chemical Components of a Traditional Herb using the Novel Informatics UNIFI Platform
The seamless integration of AI into digital pathology workflows aims to improve quality and efficiency of cancer diagnosis
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
This article tells the story of Target Malaria, a project that is fighting malaria with genetically modified mosquitoes
Next Generation Phenotypic Screening: Part of a Balanced Strategy for Accelerating Drug Discovery
Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.